Implanet To Participate At The Roth Capital 28th Conference In California
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announced today that management will participate and present at the 28th Annual ROTH Conference in Laguna Niguel, CA, to be held from Monday, March 14 to Wednesday, March 16, 2016.
IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announced today that management will participate and present at the 28th Annual ROTH Conference in Laguna Niguel, CA, to be held from Monday, March 14 to Wednesday, March 16, 2016.